Chemicals

Amyris to Acquire Fermentation-Derived Sweet Protein Developer Oobli

The deal pairs Amyris' strain engineering and manufacturing scale with Oobli's brazzein, monellin and thaumatin platforms

Kavya SridharNovember 16, 20265 min read0 views

Concept illustration of stainless-steel fermentation tanks with abstract protein helices and fruit silhouettes, evoking fermentation-derived sweet proteins.

Amyris, Inc. (Emeryville, Calif.), a vertically integrated biomanufacturing company, announced that it will acquire Oobli Inc. (Davis, Calif.), a developer of fermentation-based sweet protein ingredients that food and beverage brands use to reduce sugar without sacrificing taste.

The transaction brings together Amyris' scientific capabilities and manufacturing depth with Oobli's protein fermentation expertise, the company said. It follows Amyris' expansion of manufacturing capacity earlier this year at its advanced fermentation facility in Barra Bonita, Brazil, and is described as a strategic commercial and technology step that accelerates the company's reach into protein- and peptide-based solutions across end markets.

Kathy Fortmann, Amyris' chief executive officer, said Oobli offers a commercial and technology platform that complements Amyris' own. She said that pairing Oobli's protein know-how with Amyris' strain engineering, manufacturing scale and commercial capabilities could broaden the combined company's work in food and beverage, personal care, flavors and fragrances, agriculture and other areas.

Sweet protein portfolio

Oobli's commercial portfolio of sweet proteins is expected to be the first to benefit from the combined platform. Over the past decade the company has refined a fermentation process for producing sweet proteins that occur naturally in rare fruits and berries found near the equator. The portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit sweet proteins, known scientifically as brazzein, monellin and thaumatin. According to the company, these ingredients hold FDA GRAS status and are FEMA GRAS-affirmed for use as a natural flavor.

Sweet proteins are hundreds to thousands of times sweeter than sugar and bind directly to sweet taste receptors, according to the company, which says the body metabolizes them as protein, delivering sweetness without gut disruption or blood sugar spikes. That profile gives brands a tool for reducing sugar across categories including sports and nutrition, dairy, beverages, chocolate, bakery and confectionery, as consumer awareness of metabolic health grows.

Ali Wing, Oobli's chief executive officer, said the company has long held that there is a better way to deliver the sweet taste consumers want without trade-offs to health and the environment. Joining Amyris, she said, provides the scale and resources to pursue the ambition of making sweet proteins a global standard in sweetness solutions.

Fortmann added that biomanufactured solutions succeed when they align with consumer demand and market needs, and said Oobli's platform lets brands address sweet taste, sugar reduction and clean label at the same time.

The acquisition is expected to close in the coming weeks. Amyris said all existing customer commitments and brand partnerships will continue to be honored without interruption as Oobli's portfolio expands within the company.